Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline.

PubWeight™: 3.33‹?› | Rank: Top 1%

🔗 View Article (PMC 2694995)

Published in Infect Agent Cancer on June 01, 2009

Authors

Mark Schiffman1, Gary Clifford, Franco M Buonaguro

Author Affiliations

1: Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, 20892, USA. schiffmm@mail.nih.gov

Articles citing this

Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst (2011) 4.59

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst (2010) 3.88

Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68

Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst (2011) 2.18

Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol (2014) 1.88

A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res (2010) 1.82

Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev (2011) 1.68

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination. Hum Vaccin Immunother (2014) 1.48

A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer (2012) 1.47

Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 1.37

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer (2012) 1.34

Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat (2010) 1.28

Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany. BMC Infect Dis (2013) 1.21

Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium. J Clin Microbiol (2011) 1.15

Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol (2013) 1.11

Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One (2010) 1.09

Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana. J Med Virol (2011) 1.09

Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol (2013) 1.09

Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs. Infect Agent Cancer (2015) 1.07

Epidemiology of oral human papillomavirus infection. Oral Oncol (2013) 1.07

The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. BMC Infect Dis (2011) 1.06

Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol (2013) 1.01

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines. Br J Cancer (2010) 1.00

The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus. PLoS One (2014) 0.99

Emerging human papillomavirus vaccines. Expert Opin Emerg Drugs (2012) 0.96

Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3. PLoS One (2011) 0.94

The road ahead for cervical cancer prevention and control. Curr Oncol (2014) 0.94

Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM). PLoS One (2013) 0.93

Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Res (2010) 0.93

Alternative dosage schedules with HPV virus-like particle vaccines. Expert Rev Vaccines (2014) 0.93

Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. PLoS One (2014) 0.92

Comparison of the INNO-LiPA and PapType assays for detection of human papillomavirus in archival vulva dysplasia and/or neoplasia tissue biopsy specimens. J Clin Microbiol (2011) 0.91

NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome. Br J Cancer (2015) 0.91

HIV associated high-risk HPV infection among Nigerian women. BMC Infect Dis (2013) 0.90

Association between hTERT activation by HPV E6 proteins and oncogenic risk. Virology (2012) 0.89

Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission. Front Oncol (2013) 0.88

Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health (2014) 0.87

Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany. BMC Infect Dis (2012) 0.87

Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya. Int J Cancer (2013) 0.87

Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence. BMC Infect Dis (2012) 0.87

Genital human papillomavirus infection among women in Bangladesh: findings from a population-based survey. PLoS One (2014) 0.86

HPV prophylactic vaccination in males improves the clearance of semen infection. EBioMedicine (2015) 0.86

Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies. BMC Infect Dis (2013) 0.86

A Suggested Approach to Simplify and Improve Cervical Screening in the United States. J Low Genit Tract Dis (2016) 0.84

DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia. PLoS One (2012) 0.83

Rationale and design of the research project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS): study protocol for a randomized controlled trial. Trials (2014) 0.83

Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination. BMC Cancer (2013) 0.82

Cervicovaginal human papillomavirus (HPV)-infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV-positive and HIV-negative women. Int J Cancer (2012) 0.82

The viral E8^E2C repressor limits productive replication of human papillomavirus 16. J Virol (2013) 0.82

Impact of HPV infection on the development of head and neck cancer. Braz J Med Biol Res (2013) 0.81

A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men. Cancer Epidemiol Biomarkers Prev (2012) 0.81

A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo. Am J Cancer Res (2014) 0.81

Prevalence and genetic variability in capsid L1 gene of rare human papillomaviruses (HPV) found in cervical lesions of women from North-East Brazil. Biomed Res Int (2013) 0.81

Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci (2012) 0.80

Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Madrid, Spain. BMC Cancer (2012) 0.80

Cytological Anal Squamous Intraepithelial Lesions Associated with Anal High-Risk Human Papillomavirus Infections among Men Who Have Sex with Men in Northern Thailand. PLoS One (2016) 0.79

Development of a novel liquid bead array human papillomavirus genotyping assay (PGMY-LX) and comparison with linear array for continuity in longitudinal cohort studies. J Clin Microbiol (2015) 0.79

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev (2011) 0.79

Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya. PLoS One (2014) 0.79

Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination. PLoS One (2016) 0.79

The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya. Sex Transm Dis (2015) 0.78

Characterization of the Human Papillomavirus 16 E8 Promoter. J Virol (2015) 0.78

Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination. Oncol Lett (2016) 0.78

Degradation of Human PDZ-Proteins by Human Alphapapillomaviruses Represents an Evolutionary Adaptation to a Novel Cellular Niche. PLoS Pathog (2015) 0.78

An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors. Infect Agent Cancer (2012) 0.78

A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off. BMC Infect Dis (2014) 0.78

Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology. Clin Epigenetics (2016) 0.77

Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting. J Infect Dis (2011) 0.77

Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer. J Clin Med (2015) 0.76

A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil. BMC Cancer (2015) 0.76

Improving the Understanding of Pathogenesis of Human Papillomavirus 16 via Mapping Protein-Protein Interaction Network. Biomed Res Int (2015) 0.76

Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections. J Infect Dis (2016) 0.76

Prevalence of human papillomavirus infection in Argentinean women attending two different hospitals prior to the implementation of the National Vaccination Program. J Med Virol (2013) 0.75

Deep sequencing of HPV E6/E7 genes reveals loss of genotypic diversity and gain of clonal dominance in high-grade intraepithelial lesions of the cervix. BMC Genomics (2017) 0.75

Detection and Genotyping of Human Papillomaviruses from Archival Formalin-Fixed Tissue Samples. Curr Protoc Microbiol (2016) 0.75

Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italy. Infect Dis Obstet Gynecol (2010) 0.75

Genotype Distribution of Human Papillomavirus among Women with Cervical Cytological Abnormalities or Invasive Squamous Cell Carcinoma in a High-Incidence Area of Esophageal Carcinoma in China. Biomed Res Int (2016) 0.75

Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs. PLoS One (2015) 0.75

High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res (2016) 0.75

Human Papilloma Virus' Life Cycle and Carcinogenesis. Maedica (Buchar) (2016) 0.75

Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis (2017) 0.75

Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study. BMC Infect Dis (2016) 0.75

Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature. Int J Rheumatol (2015) 0.75

Human papillomavirus genotypes and HPV-16 variants distribution among Tunisian women with normal cytology and squamous intraepithelial lesions. Infect Agent Cancer (2016) 0.75

Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda. PLoS One (2016) 0.75

Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study. PLoS One (2016) 0.75

Association of serum cytokines with oral HPV clearance. Cytokine (2016) 0.75

Knock down of p53 or its ubiquitin ligase E6AP does not affect the sensitivity of human papillomavirus-positive cervical cancer cells to cisplatin. Am J Cancer Res (2012) 0.75

Comparison of methods using paraffin-embedded tissues and exfoliated cervical cells to evaluate human papillomavirus genotype attribution. Cancer Sci (2016) 0.75

Genotyping human papillomaviruses: development and evaluation of a comprehensive DNA microarray. Gynecol Oncol (2012) 0.75

Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology. J Clin Microbiol (2015) 0.75

Logistic analysis of epidemiologic studies with augmentation sampling involving re-stratification and population expansion. Biostatistics (2014) 0.75

Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer. Infect Agent Cancer (2014) 0.75

The association of medication use with clearance or persistence of oral HPV infection. Cancer Causes Control (2016) 0.75

Transplacental Transmission of Human Papillomavirus. Maedica (Buchar) (2015) 0.75

Human Papillomavirus Positivity in the Anal Canal in HIV-Infected and HIV-Uninfected Men Who Have Anal Sex with Men in Guangzhou, China: Implication for Anal Exams and Early Vaccination. Biomed Res Int (2017) 0.75

Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings. Ann Lab Med (2017) 0.75

Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China. J Gynecol Oncol (2017) 0.75

HPV typing of high-grade dysplasia (CIN III) in cone biopsies of 38 HPV-vaccinated women. Virchows Arch (2013) 0.75

Articles cited by this

HPV screening for cervical cancer in rural India. N Engl J Med (2009) 14.13

A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85

Human papillomavirus and cervical cancer. Lancet (2007) 12.47

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer (2007) 10.29

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis (2007) 6.86

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst (2005) 6.03

Carcinogenicity of human papillomaviruses. Lancet Oncol (2005) 5.84

The carcinogenicity of human papillomavirus types reflects viral evolution. Virology (2005) 4.72

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine (2008) 4.31

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev (2005) 3.40

A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst (2005) 2.60

Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. Int J Cancer (2008) 2.11

Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol (2005) 1.94

Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer (2009) 1.65

From India to the world--a better way to prevent cervical cancer. N Engl J Med (2009) 1.64

New technologies in cervical cancer screening. Vaccine (2008) 1.55

Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis (2006) 1.45

The evolving definition of carcinogenic human papillomavirus. Infect Agent Cancer (2009) 1.23

Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer (2008) 1.21

Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res (2007) 1.15

Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy. Br J Dermatol (2007) 1.02

The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis. Cancer Detect Prev (2005) 0.91

Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Gynecol Oncol (2006) 0.90

Articles by these authors

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis (2007) 6.86

Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol (2013) 1.48

A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology (2013) 1.44

Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. AIDS (2009) 1.42

Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics (2013) 1.24

Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer (2011) 1.23

Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer (2008) 1.21

Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer (2012) 1.17

Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol (2004) 1.13

HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes. Blood (2011) 1.13

HPV infection in Europe. Eur J Cancer (2009) 1.10

Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer (2012) 1.10

Translating tumor antigens into cancer vaccines. Clin Vaccine Immunol (2010) 1.09

Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine (2008) 1.07

Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS One (2013) 1.06

Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther (2009) 1.04

Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region. Vaccine (2008) 1.03

Update on Head and Neck Cancer: Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel Therapies. Oncology (2015) 1.03

Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol (2006) 1.02

Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. J Exp Clin Cancer Res (2009) 1.02

Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev (2010) 1.00

Effects of adjuvants on IgG subclasses elicited by virus-like particles. J Transl Med (2012) 0.99

Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int J Cancer (2008) 0.99

Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C Virus, and JC Virus. Cancer Epidemiol Biomarkers Prev (2011) 0.98

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation. J Transl Med (2005) 0.98

Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review. Gynecol Oncol (2012) 0.97

Challenges in cancer vaccine development for hepatocellular carcinoma. J Hepatol (2013) 0.95

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma. J Transl Med (2009) 0.95

Virus-like particles as particulate vaccines. Curr HIV Res (2010) 0.94

Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer (2007) 0.92

Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation. BMC Bioinformatics (2008) 0.92

Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer (2014) 0.92

Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu. Cancer Prev Res (Phila) (2012) 0.92

Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Transgenic Res (2008) 0.92

Developments in virus-like particle-based vaccines for infectious diseases and cancer. Expert Rev Vaccines (2011) 0.91

Antigen-specific vaccines for cancer treatment. Hum Vaccin Immunother (2014) 0.89

Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention. Infect Agent Cancer (2008) 0.89

Screening of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy. J Acquir Immune Defic Syndr (2004) 0.89

Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era. Virology (2010) 0.89

Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? Immunotherapy (2011) 0.87

Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus. J Clin Microbiol (2010) 0.87

TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. Infect Agent Cancer (2011) 0.87

Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies. Clin Dermatol (2013) 0.87

Systems biology applied to vaccine and immunotherapy development. BMC Syst Biol (2011) 0.85

High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts. Planta (2009) 0.84

Molecular immune signatures of HIV-1 vaccines in human PBMCs. FEBS Lett (2009) 0.83

VLPs and particle strategies for cancer vaccines. Expert Rev Vaccines (2013) 0.83

MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients. Biomarkers (2010) 0.82

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example. Retrovirology (2007) 0.82

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders. J Transl Med (2010) 0.82

Somatic mutations of STK11 gene in human papillomavirus positive and negative penile cancer. Infect Agent Cancer (2013) 0.82

Infectious agents and human malignancies. Front Biosci (Landmark Ed) (2009) 0.82

TP53 codon 72 polymorphism in classic, endemic and epidemic Kaposi's sarcoma in African and Caucasian patients. Oncology (2009) 0.82

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix. J Transl Med (2014) 0.82

Genome-wide association study of HPV seropositivity. Hum Mol Genet (2011) 0.82

Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. Infect Agent Cancer (2008) 0.81

Characterization of the human papillomavirus (HPV) integration sites into genital cancers. Pathol Oncol Res (2012) 0.81

TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda. Cancer Detect Prev (2005) 0.81

Molecular epidemiology of human herpesvirus 8 variants in Kaposi's sarcoma from Iranian patients. Virus Res (2011) 0.81

Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration. Clin Vaccine Immunol (2012) 0.81

Innate immunity and hepatitis C virus infection: a microarray's view. Infect Agent Cancer (2012) 0.80

Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model. Cancer Immunol Immunother (2015) 0.80

Evaluation of a modified version of Heteroduplex Mobility Assay for rapid screening of HIV-1 isolates in epidemics characterized by mono/dual clade predominance. J Virol Methods (2005) 0.80

High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy. APMIS (2011) 0.80

An overview of new biomolecular pathways in pathogen-related cancers. Future Oncol (2015) 0.79

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate. J Transl Med (2013) 0.78

Developments in virus-like particle-based vaccines for HIV. Expert Rev Vaccines (2013) 0.78

Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines. J Med Virol (2014) 0.78

Cellular prognostic markers in hepatocellular carcinoma. Future Oncol (2015) 0.78

Infections and cancer: debate about using vaccines as a cancer control tool. Infect Agent Cancer (2013) 0.78

Molecular characterization analysis of the outer protein layer (VP7) from human rotavirus A genotype G1 isolate identified in Iran: implications for vaccine development. New Microbiol (2012) 0.77

Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma. Cancer Lett (2008) 0.77

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis (2016) 0.77

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach. J Transl Med (2014) 0.77

Evolution of the HIV-1 V3 region in the Italian epidemic. New Microbiol (2007) 0.77

Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders. PLoS One (2012) 0.77

Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies. J Transl Med (2011) 0.76

Assessment of Chlamydia trachomatis infection among Eastern European and West African women immigrants in South Italy. Sex Transm Infect (2011) 0.76

Can HIV p24 be a suitable scaffold for presenting Env antigens? Clin Vaccine Immunol (2011) 0.76

Immunogenomics approaches for vaccine evaluation. J Immunotoxicol (2012) 0.76

Report on the 6th African Society of Human Genetics (AfSHG) Meeting, March 12-15, 2009, Yaounde, Cameroon. Am J Trop Med Hyg (2010) 0.75

Clifford et al. respond to "Biological and clinical insights from epidemiologic research into HIV, HPV, and anal cancer". Am J Epidemiol (2013) 0.75

New developments in cancer vaccines. Expert Rev Vaccines (2013) 0.75

Unsung hero Robert C. Gallo. Science (2009) 0.75

Advances in viral oncology research: summary of the 3rd International Meeting. Expert Rev Vaccines (2012) 0.75

Prospects for primary prevention of cervical cancer in developing countries. Salud Publica Mex (2003) 0.75

An overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases. Mini Rev Med Chem (2017) 0.75

Development of a stable insect cell line constitutively expressing rotavirus VP2. Virus Res (2012) 0.75

Foreword. Cancer biomarkers. Future Oncol (2015) 0.75

Systems vaccinology for cancer vaccine development. Expert Rev Vaccines (2014) 0.75